Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.

Saved in:
Bibliographic Details
Title: Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.
Authors: Zappulo, Emanuela1,2,3, Nicolini, Laura Ambra1,2, Di Grazia, Carmen4, Dominietto, Alida4, Lamparelli, Teresa4, Gualandi, Francesca4, Caligiuri, Patrizia5, Bruzzone, Bianca6, Angelucci, Emanuele4, Viscoli, Claudio1,2, Mikulska, Malgorzata1,2 m.mikulska@unige.it
Source: Infection. Feb2019, Vol. 47 Issue 1, p59-65. 7p. 1 Diagram, 1 Chart.
Database: Environment Complete
Description
ISSN:03008126
DOI:10.1007/s15010-018-1214-5